Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients - PubMed (original) (raw)

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients

Marcus J Zervos et al. J Clin Microbiol. 2012 Feb.

Abstract

Complicated skin and soft tissue infections (cSSTIs) are among the most rapidly increasing reasons for hospitalization. To describe inpatients with regard to patient characteristics, cSSTI origin, appropriateness of initial antibiotics, and outcomes, we performed a retrospective cohort study in patients hospitalized for cSSTI. To identify independent predictors of outcomes, we performed multivariate analyses. Of 1,096 eligible patients, 48.7% had health care-associated (HCA) cSSTI and 51.3% had community-acquired (CA) cSSTI. After adjustment for baseline variables, hospital length of stay (LOS) was longer for HCA than for CA cSSTI (difference, 2.1 days; 95% confidence interval [CI], 0.8 to 3.5; P < 0.05). Other covariates associated with a longer LOS were need for dialysis (regression coefficient ± standard error, 4.5 ± 1.1) and diabetic wound diagnosis (2.6 ± 1.0) (all P < 0.05). In the subset with culture-positive cSSTI within 24 h of admission, the most common pathogen was Staphylococcus aureus (298/449 [66.4%]), of which 74.8% (223/298) were methicillin-resistant S. aureus (MRSA). Eighty-three patients (18.5%) received inappropriate initial antibiotics. After adjustment for other variables, the following were associated with inappropriate initial therapy: direct admission to hospital (not via emergency department), cSSTI caused by MRSA or mixed pathogens, and cSSTI caused by pathogens other than S. aureus or streptococci (all P < 0.05). We did not find an association between inappropriate therapy and outcomes, except in the subset with ulcers (adjusted odds ratio, 11.8; 95% CI, 1.3 to 111.1; P = 0.03). More studies are needed to examine the impact of HCA cSSTI and inappropriate initial therapy on outcomes.

PubMed Disclaimer

Figures

Fig 1

Fig 1

Flow diagram of patients with cSSTIs. a, This includes patients who met the inclusion/exclusion criteria. Originally, we included randomly selected patients hospitalized in 2007. To increase the sample size, we later added patients who had positive cultures from December 2005 to October 2008. b, Culture obtained at any time during hospitalization. c, Four patients had missing pathogen information and were excluded from the analysis within 48 h; one had missing pathogen information and was excluded from the analysis within 24 h. “Appropriate” refers to appropriate initial antibiotic therapy.

Similar articles

Cited by

References

    1. Alvarez-Lerma F. 1996. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med. 22:387–394 - PubMed
    1. Chua T, et al. 2008. Molecular epidemiology of methicillin-resistant Staphylococcus aureus bloodstream isolates in urban Detroit. J. Clin. Microbiol. 46:2345–2352 - PMC - PubMed
    1. Davis SL, et al. 2007. Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J. Clin. Microbiol. 45:1705–1711 - PMC - PubMed
    1. Duan N, Manning WG, Morris CN, Newhouse JP. 1983. A comparison of alternative models for the demand for medical care. J. Bus. Econ. Stat. 1:115–126
    1. Eady EA, Cove JH. 2003. Staphylococcal resistance revisited: community-acquired methicillin resistant Staphylococcus aureus—an emerging problem for the management of skin and soft tissue infections. Curr. Opin. Infect. Dis. 16:103–124 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources